XML 123 R86.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Data (Unaudited) (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 30, 2016
Sep. 30, 2016
Dec. 29, 2017
Deferred Revenue Arrangement [Line Items]      
Accrued clinical trial liabilities $ 14,131 $ 18,700 $ 19,849
Collaborative Arrangement with Genentech [Member]      
Deferred Revenue Arrangement [Line Items]      
Recovery of net losses $ 23,100    
Recovery of net losses, recognized in current fiscal year   $ 9,800